Anika Therapeutics, Inc. (FRA:AKP)

Anika Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 9, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	118	233	300	405	455	526
Market Cap Growth	-48.37%	-22.42%	-25.82%	-11.04%	-13.52%	-20.23%
Enterprise Value	89	199	263	352	393	463
Last Close Price	7.90	15.50	20.40	27.40	32.40	34.80
PE Ratio	-	-	-	-	125.13	-
PS Ratio	1.23	2.01	2.75	3.80	3.50	4.93
PB Ratio	0.94	1.57	1.56	1.51	1.80	2.36
P/TBV Ratio	1.01	1.67	1.64	2.12	2.63	3.72
P/FCF Ratio	213.71	-	-	-	158.96	56.25
P/OCF Ratio	17.03	44.62	-	98.08	61.60	49.24
EV/Sales Ratio	0.92	1.72	2.40	3.30	3.03	4.34
EV/EBITDA Ratio	-	56.88	18.37	20.70	194.39	151.74
EV/EBIT Ratio	-	-	182.42	102.39	-	-
EV/FCF Ratio	161.59	-	-	-	137.51	49.55
Debt / Equity Ratio	0.17	0.17	0.13	0.11	0.07	0.08
Debt / EBITDA Ratio	108.08	3.48	1.42	1.44	4.12	3.52
Debt / FCF Ratio	37.82	-	-	-	6.44	1.96
Asset Turnover	0.54	0.51	0.39	0.33	0.41	0.38
Inventory Turnover	1.80	1.80	1.17	1.07	1.42	1.80
Quick Ratio	4.20	3.40	3.06	4.33	4.17	3.32
Current Ratio	5.32	4.88	5.26	6.07	5.66	4.81
Return on Equity (ROE)	-8.73%	-4.82%	-1.38%	0.77%	1.48%	-8.55%
Return on Assets (ROA)	-3.50%	-1.19%	0.32%	0.66%	-2.11%	-1.75%
Return on Capital (ROIC)	-3.89%	-1.34%	0.36%	0.73%	-2.49%	-2.01%
Return on Capital Employed (ROCE)	-6.90%	-2.50%	0.70%	1.10%	-3.80%	-3.00%
Earnings Yield	-23.86%	-23.39%	-24.92%	-3.44%	0.80%	-3.73%
FCF Yield	0.47%	-0.97%	-2.17%	-0.71%	0.63%	1.78%
Buyback Yield / Dilution	2.20%	-0.44%	-0.65%	0.50%	-2.90%	1.06%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.